Stoke Therapeutics, Inc. (STOK) Adds Bo Cumbo to Board
Stoke Therapeutics appointed Bo Cumbo to its Board of Directors as Edward Kaye, M.D., retires from the Board and will advise during the transition. The move adds commercial expertise as Stoke advances zorevunersen toward potential FDA approval and commercialization.Material DetailsContext by AI Ana…